AOD-9604 vs Ipamorelin

A detailed comparison to help you understand the differences and choose the right peptide for your research goals.

AOD-9604

AOD-9604 is a modified fragment of human growth hormone (HGH fragment 176-191). It was developed to have the fat-reducing effects of growth hormone without the adverse effects on blood sugar or growth.

Full details →

Ipamorelin

Ipamorelin is a selective growth hormone secretagogue that stimulates the release of growth hormone from the pituitary gland without significantly affecting cortisol or prolactin.

Full details →

Side-by-Side Comparison

Aspect	AOD-9604	Ipamorelin
Dose Range	300 mcg–500 mcg	100 mcg–300 mcg
Frequency	1x daily	2x daily
Cycle Length	12–24 weeks	8–12 weeks
Route	subcutaneous	subcutaneous
Mechanism	Stimulates lipolysis (fat breakdown) and inhibits lipogenesis (fat accumulation) without affecting blood sugar or growth. Works specifically on adipose tissue through a mechanism independent of GH receptors.	Acts as a ghrelin mimetic, binding to the ghrelin receptor (GHS-R) in the pituitary to stimulate GH release. Highly selective with minimal effect on other hormones.
Typical Dosage	Research dosing typically ranges from 250-500mcg daily, often split into morning and afternoon doses. Some protocols use higher doses up to 1mg.	Typical dosing ranges from 200-300mcg administered 2-3 times daily, often combined with CJC-1295.
Administration	Subcutaneous injection, typically in the abdominal area. Best administered on an empty stomach. Can be combined with exercise for enhanced effects.	Subcutaneous injection. Best results when administered fasted or before sleep. Often stacked with GHRH peptides.
Side Effects	Generally well-tolerated. May cause headaches, injection site reactions, or temporary lethargy. Does not affect blood glucose like full GH.	Generally well-tolerated. May cause mild headaches, lightheadedness, or increased hunger initially.
Best For	Fat Loss	Muscle Growth Fat Loss Recovery & Healing Sleep Quality